Jasmine N Khouja1,2,3, Robyn E Wootton1,2, Amy E Taylor2,4, George Davey Smith1,2, Marcus R Munafò1,3,4. 1. MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom. 2. Bristol Medical School: Population Health Sciences, University of Bristol, Bristol, United Kingdom. 3. School of Psychological Science, University of Bristol, Bristol, United Kingdom. 4. NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol, Bristol, United Kingdom.
Abstract
BACKGROUND: Tobacco smoking and e-cigarette use are strongly associated, but it is currently unclear whether this association is causal, or due to shared factors that influence both behaviours such as a shared genetic liability. The aim of this study was to investigate whether polygenic risk scores (PRS) for smoking initiation are associated with ever use of e-cigarettes. METHODS AND FINDINGS: Smoking initiation PRS were calculated for young adults (N = 7,859, mean age = 24 years, 51% male) of European ancestry in the Avon Longitudinal Study of Parents and Children, a prospective birth cohort study initiated in 1991. PRS were calculated using the GWAS & Sequencing Consortium of Alcohol and Nicotine use (GSCAN) summary statistics. Five thresholds ranging from 5 × 10-8 to 0.5 were used to calculate 5 PRS for each individual. Using logistic regression, we investigated the association between smoking initiation PRS and the main outcome, self-reported e-cigarette use (n = 2,894, measured between 2016 and 2017), as well as self-reported smoking initiation and 8 negative control outcomes (socioeconomic position at birth, externalising disorders in childhood, and risk-taking in young adulthood). A total of 878 young adults (30%) had ever used e-cigarettes at 24 years, and 150 (5%) were regular e-cigarette users at 24 years. We observed positive associations of similar magnitude between smoking initiation PRS (created using the p < 5 × 10-8 threshold) and both smoking initiation (odds ratio (OR) = 1.29, 95% CI 1.19 to 1.39, p < 0.001) and ever e-cigarette use (OR = 1.24, 95% CI 1.14 to 1.34, p < 0.001) by the age of 24 years, indicating that a genetic predisposition to smoking initiation is associated with an increased risk of using e-cigarettes. At lower p-value thresholds, we observed an association between smoking initiation PRS and ever e-cigarette use among never smokers. We also found evidence of associations between smoking initiation PRS and some negative control outcomes, particularly when less stringent p-value thresholds were used to create the PRS, but also at the strictest threshold (e.g., gambling, number of sexual partners, conduct disorder at 7 years, and parental socioeconomic position at birth). However, this study is limited by the relatively small sample size and potential for collider bias. CONCLUSIONS: Our results indicate that there may be a shared genetic aetiology between smoking and e-cigarette use, and also with socioeconomic position, externalising disorders in childhood, and risky behaviour more generally. This indicates that there may be a common genetic vulnerability to both smoking and e-cigarette use, which may reflect a broad risk-taking phenotype.
BACKGROUND: Tobacco smoking and e-cigarette use are strongly associated, but it is currently unclear whether this association is causal, or due to shared factors that influence both behaviours such as a shared genetic liability. The aim of this study was to investigate whether polygenic risk scores (PRS) for smoking initiation are associated with ever use of e-cigarettes. METHODS AND FINDINGS: Smoking initiation PRS were calculated for young adults (N = 7,859, mean age = 24 years, 51% male) of European ancestry in the Avon Longitudinal Study of Parents and Children, a prospective birth cohort study initiated in 1991. PRS were calculated using the GWAS & Sequencing Consortium of Alcohol and Nicotine use (GSCAN) summary statistics. Five thresholds ranging from 5 × 10-8 to 0.5 were used to calculate 5 PRS for each individual. Using logistic regression, we investigated the association between smoking initiation PRS and the main outcome, self-reported e-cigarette use (n = 2,894, measured between 2016 and 2017), as well as self-reported smoking initiation and 8 negative control outcomes (socioeconomic position at birth, externalising disorders in childhood, and risk-taking in young adulthood). A total of 878 young adults (30%) had ever used e-cigarettes at 24 years, and 150 (5%) were regular e-cigarette users at 24 years. We observed positive associations of similar magnitude between smoking initiation PRS (created using the p < 5 × 10-8 threshold) and both smoking initiation (odds ratio (OR) = 1.29, 95% CI 1.19 to 1.39, p < 0.001) and ever e-cigarette use (OR = 1.24, 95% CI 1.14 to 1.34, p < 0.001) by the age of 24 years, indicating that a genetic predisposition to smoking initiation is associated with an increased risk of using e-cigarettes. At lower p-value thresholds, we observed an association between smoking initiation PRS and ever e-cigarette use among never smokers. We also found evidence of associations between smoking initiation PRS and some negative control outcomes, particularly when less stringent p-value thresholds were used to create the PRS, but also at the strictest threshold (e.g., gambling, number of sexual partners, conduct disorder at 7 years, and parental socioeconomic position at birth). However, this study is limited by the relatively small sample size and potential for collider bias. CONCLUSIONS: Our results indicate that there may be a shared genetic aetiology between smoking and e-cigarette use, and also with socioeconomic position, externalising disorders in childhood, and risky behaviour more generally. This indicates that there may be a common genetic vulnerability to both smoking and e-cigarette use, which may reflect a broad risk-taking phenotype.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Andrea G Allegrini; Karin J H Verweij; Abdel Abdellaoui; Jorien L Treur; Jouke-Jan Hottenga; Gonneke Willemsen; Dorret I Boomsma; Jacqueline M Vink Journal: Nicotine Tob Res Date: 2019-05-21 Impact factor: 4.244
Authors: Andy Boyd; Jean Golding; John Macleod; Debbie A Lawlor; Abigail Fraser; John Henderson; Lynn Molloy; Andy Ness; Susan Ring; George Davey Smith Journal: Int J Epidemiol Date: 2012-04-16 Impact factor: 7.196
Authors: Amy E Taylor; Hannah J Jones; Hannah Sallis; Jack Euesden; Evie Stergiakouli; Neil M Davies; Stanley Zammit; Debbie A Lawlor; Marcus R Munafò; George Davey Smith; Kate Tilling Journal: Int J Epidemiol Date: 2018-08-01 Impact factor: 7.196
Authors: Kate Northstone; Melanie Lewcock; Alix Groom; Andy Boyd; John Macleod; Nicholas Timpson; Nicholas Wells Journal: Wellcome Open Res Date: 2019-03-14
Authors: Jorien L Treur; Ditte Demontis; George Davey Smith; Hannah Sallis; Tom G Richardson; Reinout W Wiers; Anders D Børglum; Karin J H Verweij; Marcus R Munafò Journal: Addict Biol Date: 2019-11-16 Impact factor: 4.280
Authors: Lion Shahab; Jamie Brown; Lies Boelen; Emma Beard; Robert West; Marcus R Munafò Journal: Nicotine Tob Res Date: 2022-07-13 Impact factor: 5.825
Authors: Flavio De Angelis; Frank R Wendt; Gita A Pathak; Daniel S Tylee; Aranyak Goswami; Joel Gelernter; Renato Polimanti Journal: Transl Psychiatry Date: 2021-11-13 Impact factor: 6.222
Authors: Kellyn M Spychala; Ian R Gizer; Christal N Davis; Genevieve F Dash; Thomas M Piasecki; Wendy S Slutske Journal: Addiction Date: 2021-09-08 Impact factor: 7.256
Authors: Jorien L Treur; Marcus R Munafò; Emma Logtenberg; Reinout W Wiers; Karin J H Verweij Journal: Psychol Med Date: 2021-05-25 Impact factor: 7.723
Authors: Laura Schellhas; Elis Haan; Kayleigh E Easey; Robyn E Wootton; Hannah M Sallis; Gemma C Sharp; Marcus R Munafò; Luisa Zuccolo Journal: Addiction Date: 2021-05-10 Impact factor: 7.256